| | | N2-ISOBUTYRYL-2'-O,4'-C-METHYLENEGUANOSINE CAS:206055-68-7 Formula: C15H19N5O6 GëÑ95% 206055-68-7 guanosine, 2'-O,4'-C-methylene-N-(2-methyl-1-oxopropyl)-; (1S,3R,4R,7S)-7-Hydroxy-1-hydroxymethyl-3-(2-N-isobutyrylguanin-9-yl)-2,5-dioxabicyclo[2.2.1]heptane; N-[6,9-Dihydro-6-oxo-9-[(1S,3R,4R,7S)-1-(hydroxymethyl)-7-hydroxy-2,5-dioxabicyc N2-ISOBUTYRYL-3',5'-O-(1,1,3,3-TETRAISOPROPYL-1,3-DISILOXANEDIYL)GUANOSINE CAS:87865-78-9 Formula: C26H45N5O7Si2 GëÑ95% 87865-78-9 N2-Isobutyryl-3',5'-O-TIPPS-guanosine; 3',5'-O-TIPPS-N2-isobutyrylguanosine; N2-Isobutyryl-3',5'-O-(1,1,3,3-tetraisopropyl-1,3-disiloxanediyl)-D-guanosine; 9-[3,5-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-+¦-D-ribofuranosyl]-N2-isobutyry N3,5-DIMETHYL-2,3-PYRIDINEDIAMINE CAS:155790-04-8 Formula: C7H11N3 BB066879 3-N,5-dimethylpyridine-2,3-diamine; 2,3-Pyridinediamine,N3,5-dimethyl-(9CI); 2,3-Pyridinediamine, N3,5-dimethyl- N3-METHYLPSEUDOURIDINE CAS:81691-06-7 Formula: C10H14N2O6 GëÑ95% B2706-340278 3-Methyl-5-(beta-D-ribofuranosyl)uracil; 2,4(1H,3H)-Pyrimidinedione, 3-methyl-5-beta-D-ribofuranosyl-; 3-Methyl-5-+¦-D-ribofuranosyl-2,4(1H,3H)-pyrimidinedione; NSC 363818; (1S)-1,4-Anhydro-1-(3-methyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidi N4,N4,2'-O-TRIMETHYLCYTIDINE CAS:34218-81-0 Formula: C12H19N3O5 GëÑ95% by HPLC 34218-81-0 Cytidine, N4,N4-dimethyl-2'-O-methyl-; N(4),N(4),O(2')-Trimethylcytidine; N,N,2'-O-Trimethylcytidine; 1-((2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-4-(dimethylamino)pyrimidin-2(1H)-one; N,N-Dimethyl-2'-O-methylcytid N4-[5-[[4-[[5-(ACETYLHYDROXYAMINO)PENTYL]AMINO]-1,4-DIOXOBUTYL]HYDROXYAMINO]PENTYL]-N1-[5-[[3-(2,5-DIHYDRO-2,5-DIOXO-1H-PYRROL-1-YL)-1-OXOPROPYL]AMINO]PENTYL]-N1-HYDROXYBUTANEDIAMIDE CAS:1638156-31-6 Formula: C32H53N7O11 BB054859 N-(3,11,14,22,25,33-hexaoxo-4,10,15,21,26,32-hexaaza-10,21,32- trihydroxytetratriacontane)maleimide N4-ACETYL-3',5'-O-(1,1,3,3-TETRAISOPROPYL-1,3-DISILOXANEDIYL)CYTIDINE CAS:85335-73-5 Formula: C23H41N3O7Si2 GëÑ98% 85335-73-5 3',5'-O-TIPPS-N4-acetylcytidine; N4-Acetyl-3',5'-O-TIPPS-cytidine; N-Acetyl-3',5'-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]cytidine; N4-Acetyl-3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)cytidine; 3',5'-TIPS-N-Ac-Cytidine N4-BANZOYL-5-METHYL-2'-O,4'-C-METHYLENECYTIDINE CAS:206055-81-4 Formula: C18H19N3O6 GëÑ95% 206055-81-4 (1S,3R,4R,7S)-7-hydroxy-1-hydroxymethyl-3-(5-methyl-4-N-benzoylcytosine-1-yl)-2,5-dioxabicyclo[2.2.1]heptane; N-[1-[(1S,3R,4R,7S)-7-hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide; (1S,3R N4-BENZOYL-3 ,5 -O-(1,1,3,3-TETRAISOPROPYL-1,3-DISILOXANEDIYL)CYTIDINE CAS:69304-43-4 Formula: C28H43N3O7Si2 GëÑ98% 69304-43-4 N-Benzoyl-3',5'-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-Cytidine; 3',5'-TIPS-N-Bz-Cytidine; N4-Benzoyl-3',5'-O-(1,1,3,3-tetraisopropyl-1,3-disiloxanediyl)cytidine; 3',5'-TIPS-N4-Benzoyl-cytidine N4-DESMETHYL-N5-METHYL WYOSINE CAS:59327-63-8 Formula: C14H17N5O5 GëÑ95% 59327-63-8 5-Methyl-4-desomethylwyosine; 5,6-dimethyl-3-+¦-D-ribofuranosyl-3,6-dihydro-imidazo[1,2-a]purin-9-one; 9H-Imidazo[1,2-a]purin-9-one, 3,5-dihydro-5,6-dimethyl-3-+¦-D-ribofuranosyl-; 3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]- N4-Hydroxycytidine-[13C,15N2] Formula: C8[13C]H13N[15N]2O6 >95% BLP-014963 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(hydroxyimino)-3,4-dihydropyrimidin-2(1H)-one-2-13C-1,3-15N2; [13C,15N2]-N4-Hydroxycytidine; EIDD 1931-13C,15N2; N-Hydroxycytidine-13C,15N2; N4-Hydroxycytidine-13C,15N2 N5-HYDROXYLAMINO CASPOFUNGIN CAS:1671884-42-6 Formula: C52H88N10O16 1671884-42-6 (10R,12S)-N-((2R,6S,9S,11R,12R,14aS,15S,20S,23S,25aS)-20-((R)-3-amino-1-hydroxypropyl)-12-((2-aminoethyl)(hydroxy)amino)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)-2,11,15-trihydroxy-6-((R)-1-hydroxyethyl)-5,8,14,19,22,25-hexaoxote N5-HYDROXYLAMINO CASPOFUNGIN DIACETATE CAS:1671884-43-7 Formula: C52H88N10O16.2C2H4O2 >98% 1671884-43-7 (10R,12S)-N-((2R,6S,9S,11R,12R,14aS,15S,20S,23S,25aS)-20-((R)-3-amino-1-hydroxypropyl)-12-((2-aminoethyl)(hydroxy)amino)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)-2,11,15-trihydroxy-6-((R)-1-hydroxyethyl)-5,8,14,19,22,25-hexaoxote N6,N6,2'-O-Trimethyladenosine CAS:30891-53-3 Formula: C13H19N5O4 GëÑ95% 30891-53-3 Adenosine, N,N-dimethyl-2'-O-methyl-; (2R,3R,4R,5R)-5-(6-(Dimethylamino)-9H-purin-9-yl)-2-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol; N,N-Dimethyl-2'-O-methyladenosine; N6,N6-Dimethyl-2'-O-methyladenosine; N,N-Dimethyl-9-[(2++)-2-O-methyl N6-(4,5-Dihydro-4,4-dimethyl-2-thiazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4,6-quinazolinediamine CAS:937266-01-8 Formula: C26H24N8OS BB068675 N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrothiazol-2-yl)quinazoline-4,6-diamine NADOLOL IMPURITY 1 Formula: C26H35NO8 > 95% (2S,3R)-rel-5-(3-(((6R,7S)-rel-6,7-Dihydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)oxy)-2-hydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol; NAGILACTONE B CAS:19891-51-1 Formula: C19H24O7 > 95% NP1439 (1S)-1,2,3,3a,5a+¦,6,10b,10c+¦-Octahydro-1,2+¦,6+¦-trihydroxy-3a+¦,10b+¦-dimethyl-7-isopropyl-4H,9H-furo[2',3',4':4,5]naphtho[2,1-c]pyran-4,9-dione NALOXEGOL CAS:854601-70-0 Formula: C34H53NO11 >98% 854601-70-0 Movantik;NKTR-118; NKTR 118; NKTR118; (4R,4aS,7S,7aR,12bS)-7-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-3-prop-2-enyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol NALOXEGOL OXALATE CAS:1354744-91-4 Formula: C36H55NO15 >98% B0084-465947 Morphinan-3,14-diol, 4,5-epoxy-6-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propen-1-yl)-, (5+¦,6+¦)-, ethanedioate (1:1); AZ 13337019 oxalate; AZ13337019 oxalate; AZ-13337019 oxalate; Moventig; NKTR 118 oxalate; (4R,4aS,7S,7aR,12bS)-7-( NALOXEGOL-[13C,D2] Formula: C33[13C]H51D2NO11 >98% BLP-004906 Naloxegol 13CD2; (5+¦,6+¦)-4,5-Epoxy-6-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propenyl)-morphinan-3,14-diol-13C,d2; Movantik-13C,d2; NKTR 118-13C,d2 NALOXEGOL-[13C,D3] Formula: C33[13C]H50D3NO11 >98% BLP-004907 Naloxegol 13CD3; (5+¦,6+¦)-4,5-Epoxy-6-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propenyl)-morphinan-3,14-diol-13C,d3; Movantik-13C,d3; NKTR 118-13C,d3 NALTREXONE-[9,15,16-13C3,17-15N] Formula: C17[13C]3H23[15N]O4 95% by CP; 98% atom 13C; 98% atom 15N BLP-008505 17-(cyclopropylmethyl)-4,5+¦-epoxy-3,14-dihydroxymorphinan-6-one-13C3,15N; (-)-Naltrexone-13C3,15N; 1-N-Cyclopropylmethyl-7,8-dihydro-14-hydroxynormorphinone-13C3,15N; Depotrex-13C3,15N; N-Cyclopropylmethylnoroxymorphone-13C3,15N NANANGENINE B CAS:1609469-72-8 Formula: C21H32O6 >95% by HPLC 1609469-72-8 Nanangenine B; 1609469-72-8; CHEMBL3261196; [(5R,5As,9R,9aR,9bR)-9,9b-dihydroxy-6,6,9a-trimethyl-1-oxo-3,5,5a,7,8,9-hexahydrobenzo[e][2]benzofuran-5-yl] hexanoate; hexanoic acid, (5R,5aS,9R,9aR,9bR)-1,3,5,5a,6,7,8,9,9a,9b-decahydro-9,9b-dih NANAOMYCIN B CAS:52934-85-7 Formula: C16H16O7 BBF-01981 Antibiotic OS 3966B; 1H-Naphtho(2,3-c)pyran-3-acetic acid, 3,4,4a,5,10,10a-hexahydro-9,10a-dihydroxy-1-methyl-5,10-dioxo-, (1S-(1-alpha,3-beta,4a-alpha,10a-beta))- NANAOMYCIN E CAS:72660-52-7 Formula: C16H14O7 BBF-01984 4a,10a-Epoxy-1H-naphtho(2,3-c)pyran-3-acetic acid, 3,4,5,10-tetrahydro-9-hydroxy-1-methyl-5,10-dioxo-, (1S-(1alpha,3beta,4abeta,10abeta))- NANCHANGMYCIN CAS:65101-87-3 Formula: C17H21N3O2S >98% 65101-87-3 Nanchangmycin;Nanchangmycin A;65101-87-3;Sodium;(E,2S,4R,8S)-8-[(2S,5R,7S,8R,9R)-7-hydroxy-2-[(2R,4S,5S,7R,9S,10R)-2-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-9-[(2S,5S,6R)-5-methoxy-6-methyloxan-2-yl]oxy-4,10-dimeth NAPHTHALENE-1-BORONIC ACID PINACOL ESTER CAS:68716-52-9 Formula: C16H19O2B BB033618 4,4,5,5-tetramethyl-2-(1-naphthalenyl)-1,3,2-dioxaborolane; 4,4,5,5-tetramethyl-2-naphthalen-1-yl-1,3,2-dioxaborolane NAPHTHALENE-2-BORONIC ACID PINACOL ESTER CAS:256652-04-7 Formula: C16H19O2B 98 % BB018999 4,4,5,5-tetramethyl-2-(2-naphthalenyl)-1,3,2-dioxaborolane; 4,4,5,5-tetramethyl-2-naphthalen-2-yl-1,3,2-dioxaborolane Naphthalenediol, 5-(1,5-dimethyl-4-hexenyl)-5,6,7,8-tetrahydro-8-(hydroxymethyl)-3-methyl-, [5S-[5+¦(R*),7+¦,8+¦]]-, 1,7- CAS:104021-12-7 Formula: C20H30O3 BBF-04877 NAPHTHO[1,2-B]FURAN-2(3H)-ONE,3A,4,5,5A,6,7,9A,9B-OCTAHYDRO-6-HYDROXY-5A,9-DIMETHYL-3-METHYLENE-,(3AS,5AR,6R,9AS,9BS)- CAS:4290-13-5 Formula: C15H20O3 >98% NP5549 SANTAMARIN; (3aS)-2,3,3a+¦,4,5,5a,6,7,9a+¦,9b+¦-Decahydro-6+¦-hydroxy-5a+¦,9-dimethyl-3-methylenenaphtho[1,2-b]furan-2-one; Balchanin; (3aS,5aR,6R,9aS,9bS)-6-hydroxy-5a,9-dimethyl-3-methylene-4,5,6,7,9a,9b-hexahydro-3aH-benzo[g]benzofuran-2-one; NAPHTHO[1,8-EF]-1,4-DIAZEPINE-2-ACETAMIDE, 1,2,3,4-TETRAHYDRO-3-OXO- CAS:1009278-40-3 Formula: C14H13N3O2 BB058822 2-(3-Oxo-1,2,3,4-tetrahydronaphtho[1,8-ef][1,4]diazepin-2-yl)acetamide;1,2,3,4-Tetrahydro-3-oxo-naphtho[1,8-ef]-1,4-diazepine-2-acetamide NAPROXEN-[13C,D3] Formula: C13[13C]H11D3O3 >95% BLP-015129 (S)-2-(6-Methoxynaphthalen-2-yl)propanoic-3-13C-3,3,3-d3 acid; Naproxen 13C D3; Aproxen-13C,d3; Dysmenalgit-13C,d3; Equiproxen-13C,d3; Floginax-13C,d3; Laraflex-13C,d3; MNPA-13C,d3; Prexan-13C,d3; (+¦S)-6-Methoxy-+¦-methyl-2-naphthaleneacetic Naproxen-[Methoxy-13C,d3] CAS:1261392-52-2 Formula: C13[13C]H11D3O3 >98% BLP-004908 Naproxen-[13C,d3]; Naproxen 13CD3; (S)-6-Methoxy-13C,d3-+¦-methyl-2-naphthaleneacetic Acid; po-Naproxen-13C,d3; Aproxen-13C,d3; Dysmenalgit-13C,d3; Equiproxen-13C,d3; Floginax-13C,d3; Laraflex-13C,d3; MNPA-13C,d3; Prexan-13C,d3; (+¦S)-6-(Meth NAPYRADIOMYCIN A1 CAS:103106-24-7 Formula: C25H30Cl2O5 BBF-02572 napyradiomycin A1; 3,4a-Dichloro-6,8-dihydroxy-3,4,4a,10a-tetrahydro-2,2-dimethyl-10a-(3,7-dimethyl-2,6-octadienyl)-2H-naphtho[2,3-b]pyran-5,10-dione; Napyradiomycin A; WS-9558A |